IRIS
- romanberenblyum
- May 1, 2017
- 1 min read
1 May 2017
IRIS-Forskningsinvest AS has signed an agreement with Hydrogen Source AS and transferred all patent and technology commercialization rights for “In situ hydrogen generation” technology to Hydrogen Source AS.
Comments